In this episode of Telltales, Mike Nicoletti, Jason Wallace, and Hunt Lawrence analyze global energy markets, the cash flow profiles of the world’s largest technology companies, and key developments in biotech and healthcare investing.

[00:00] Introduction

Mike introduces the episode and the Cash Flow Memo, which tracks financials across major companies and macro exhibits covering U.S. government finances, oil, and natural gas.

[00:29] Oil Markets and Iran Tensions

Hunt explains how geopolitical tensions involving Iran and shipping through the Strait of Hormuz are affecting oil prices and global supply dynamics.

[03:00] Natural Gas, LNG, and Permian Supply

The hosts discuss LNG disruptions from Qatar, rising global gas prices, and the persistent oversupply of U.S. natural gas driven by Permian Basin associated gas.

[05:41] U.S. Government Finances

A look at the U.S. fiscal picture, including deficit trends, tariff revenue, and the continued role of the dollar as a global reserve currency.

[07:04] Mega-Cap Tech Financials

Apple, Amazon, Alphabet, Microsoft, and Tesla are compared through the lens of revenue, EBITDA, capital spending, and free cash flow.

[11:44] Amazon vs Walmart

The panel breaks down Amazon as two businesses—retail and cloud—and compares its economics with Walmart’s massive retail operation.

[16:21] Nvidia’s Cash Flow Machine

Nvidia’s extraordinary margins and free cash flow generation are highlighted, along with discussion of the sustainability of AI-driven demand.

[18:00] Moats in the AI Era

The hosts debate competitive advantages among major tech companies, including risks facing Apple, Alphabet, Microsoft, and Nvidia as AI reshapes the industry.

[20:33] Biotech Leadership Changes

Discussion turns to BioNTech and Moderna, including founder departures and how early-stage research cultures influence biotech companies.

[24:00] Pharma R&D and Capital Allocation

The hosts analyze R&D spending at companies like Pfizer and Vertex, focusing on how capital allocation affects long-term drug pipelines.

[25:53] Harrow’s Outlook

The team reviews Harrow’s recent results and guidance, explaining why the long-term thesis remains intact despite short-term market reactions.

[27:38] AI Predictions

Each host offers predictions about near-term developments in artificial intelligence, including the possibility of new model breakthroughs and Microsoft’s next Copilot evolution.

[31:50] Closing Remarks

The episode concludes with final thoughts and a preview of next week’s discussion.

If you enjoy deep dives into company cash flows and long-term investing, subscribe to Telltales and download the Cash Flow Memo at telltales.us.

This podcast and the information herein are intended for informational purposes only. The views expressed herein are the author’s alone and do not constitute an offer to sell, or a recommendation to purchase, or a solicitation of an offer to buy, any security, nor a recommendation for any investment product or service. While certain information contained herein has been obtained from sources believed to be reliable, neither the author nor any of his employers or their affiliates have independently verified this information, and its accuracy and completeness cannot be guaranteed. Accordingly, no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, timeliness or completeness of this information. The author and all employers and their affiliated persons assume no liability for this information and no obligation to update the information or analysis contained herein in the future.

This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit telltales.substack.com